azimilide, sotalol
DISEASE INTERVENTION COMPARISON RESULTS
Eur Heart J. 2006 Sep;27(18):2224-31. Epub 2006 Aug 25 Randomized Controlled Trial
IN StudyID: A-COMET-II 2006, atrial fibrillation The Use of
azimilide, sotalol
As Treatment, Chronic
Is better Than
placebo
To prevent, at 6 months, AF recurrence without being stopped because adverse effects: sotalol 33% VS 19% azim VS 15% placebo. Both azimilide and sotalol increased proarrhythmia.